Schroder Investment Management Group
COGT icon

Schroder Investment Management Group’s Cogent Biosciences COGT Stock Holding History

Schroder Investment Management Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Hold
53,307
– – ﹤0.01% 924
2026
Q1 		$1.89M Hold
53,307
– – ﹤0.01% 945
2025
Q4 		$1.98M Sell
53,307
-126,426
-70% -$3.55M ﹤0.01% 891
2025
Q3 		$2.54M Buy
179,733
+55,005
+44% +$652K ﹤0.01% 888
2025
Q2 		$896K Buy
+124,728
New +$691K ﹤0.01% 1002
2024
Q3 		– Sell
-16,598
Closed -$140K – 1211
2024
Q2 		$140K Buy
+16,598
New +$126K ﹤0.01% 1177
2024
Q1 		– Sell
-135,000
Closed -$794K – 1205
2023
Q4 		$794K Buy
+135,000
New +$1.03M ﹤0.01% 1043

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Schroder Investment Management Group's COGT Position: Q2 2026 in Review

Schroder Investment Management Group held its Cogent Biosciences (COGT) position steady in Q2 2026 at 53,307 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Schroder Investment Management Group first reported a position in COGT in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.54M in Q3 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Schroder Investment Management Group held 53,307 shares of Cogent Biosciences worth $2.07M as of Q2 2026.
  • Schroder Investment Management Group left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #924 holding.
  • Schroder Investment Management Group first reported a position in Cogent Biosciences in Q4 2023 and has held it in 7 quarters since.
  • Schroder Investment Management Group's Cogent Biosciences position peaked at $2.54M in Q3 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.